Literature DB >> 26893655

Fangchinoline inhibits the proliferation of SPC-A-1 lung cancer cells by blocking cell cycle progression.

Xue Luo1, Jian-Ming Peng2, Lan-DI Su1, Dong-Yan Wang1, You-Jiang Yu1.   

Abstract

Fangchinoline (Fan) is a bioactive compound isolated from the Chinese herb Stephania tetrandra S. Moore (Fen Fang Ji). The aim of the present study was to investigate the effect of Fan on the proliferation of SPC-A-1 lung cancer cells, and to define the associated molecular mechanisms. Following treatment with Fan, Cell Counting Kit-8, phase contrast imaging and Giemsa staining assays were used to detect cell viability; flow cytometry was performed to analyze the cell cycle distribution; and reverse transcription-quantitative polymerase chain reaction and western blot assays were used to investigate changes in the expression levels of cell cycle-associated genes and proteins. In the present study, treatment with Fan markedly inhibited the proliferation of SPC-A-1 lung cancer cells and significantly increased the percentage of cells in the G0/G1 phase of the cell cycle in a dose-dependent manner (P<0.05 for 2.5-5 µm; P<0.01 for 10 µm), whereas the percentage of cells in the S and G2/M phases were significantly reduced following treatment (P<0.05 for 5 µm; P<0.01 for 10 µm). Mechanistically, Fan significantly reduced the mRNA expression levels of cyclin D1, cyclin-dependent kinase 4 (CDK4) and CDK6 (P<0.05 for 2.5-5 µm; P<0.01 for 10 µm), which are key genes in the regulation of the G0/G1 phase of the cell cycle. Furthermore, treatment with Fan also decreased the expression of phosphorylated retinoblastoma (Rb) and E2F transcription factor-1 (E2F-1) proteins (P<0.05 for 5 µm; P<0.01 for 10 µm). In summary, the present study demonstrated that Fan inhibited the proliferation of SPC-A-1 lung cancer cells and induced cell cycle arrest at the G0/G1 phase. These effects may be mediated by the downregulation of cellular CDK4, CDK6 and cyclin D1 levels, thus leading to hypophosphorylation of Rb and subsequent suppression of E2F-1 activity. Therefore, the present results suggest that Fan may be a potential drug candidate for the prevention of lung cancer.

Entities:  

Keywords:  cell cycle; cyclin D1; fangchinoline; lung cancer; retinoblastoma

Year:  2015        PMID: 26893655      PMCID: PMC4734059          DOI: 10.3892/etm.2015.2915

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  20 in total

Review 1.  Cdks, cyclins and CKIs: roles beyond cell cycle regulation.

Authors:  Shuhui Lim; Philipp Kaldis
Journal:  Development       Date:  2013-08       Impact factor: 6.868

Review 2.  RB and cell cycle progression.

Authors:  C Giacinti; A Giordano
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

3.  Natural pesticide dihydrorotenone arrests human plasma cancer cells at the G0/G1 phase of the cell cycle.

Authors:  Xin Xu; Jieyu Zhang; Kunkun Han; Zubin Zhang; Guodong Chen; Jinping Zhang; Xinliang Mao; Biyin Cao
Journal:  J Biochem Mol Toxicol       Date:  2014-03-10       Impact factor: 3.642

4.  Fangchinoline inhibits breast adenocarcinoma proliferation by inducing apoptosis.

Authors:  Zhi-Bo Xing; Lei Yao; Guo-Qiang Zhang; Xian-Yu Zhang; You-Xue Zhang; Da Pang
Journal:  Chem Pharm Bull (Tokyo)       Date:  2011       Impact factor: 1.645

5.  Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells.

Authors:  Ning Wang; Weidong Pan; Meifen Zhu; Maosheng Zhang; Xiaojian Hao; Guangyi Liang; Yibin Feng
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

6.  Fangchinoline induced G1/S arrest by modulating expression of p27, PCNA, and cyclin D in human prostate carcinoma cancer PC3 cells and tumor xenograft.

Authors:  Chang-Dong Wang; Jian-Guo Huang; Xuan Gao; Yi Li; Shi-Yi Zhou; Xu Yan; An Zou; Jun-Li Chang; Yue-Sheng Wang; Guang-Xiao Yang; Guang-Yuan He
Journal:  Biosci Biotechnol Biochem       Date:  2010-03-07       Impact factor: 2.043

Review 7.  Switching cyclin D-Cdk4 kinase activity on and off.

Authors:  Stacy W Blain
Journal:  Cell Cycle       Date:  2008-01-18       Impact factor: 4.534

8.  Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition.

Authors:  Yi-Xin Wang; Hong Cai; Gang Jiang; Tian-Bao Zhou; Hai Wu
Journal:  Asian Pac J Cancer Prev       Date:  2014

9.  Histamine release inhibition activity of bisbenzylisoquinoline alkaloids.

Authors:  K Nakamura; S Tsuchiya; Y Sugimoto; Y Sugimura; Y Yamada
Journal:  Planta Med       Date:  1992-12       Impact factor: 3.352

Review 10.  The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Shi Guang Li; Hai Yong Chen; Chen Sheng Ou-Yang; Xi-Xin Wang; Zhen-Jiang Yang; Yao Tong; William C S Cho
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more
  8 in total

1.  Plant Alkaloid Tetrandrine Is a Nuclear Receptor 4A1 Antagonist and Inhibits Panc-1 Cell Growth In Vitro and In Vivo.

Authors:  Hyo-Seon Lee; Dae Hwan Kim; In-Seon Lee; Ji-Hyun Park; Gregory Martin; Stephen Safe; Keuk-Jun Kim; Joung-Hee Kim; Byung Ik Jang; Syng-Ook Lee
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

2.  Fangchinoline attenuates cardiac dysfunction in rats with endotoxemia via the inhibition of ERK1/2 and NF-κB p65 phosphorylation.

Authors:  Hongwei Chen; Zonghua Shi; Yongsheng Xing; Xinwei Li; Fengzhou Fu
Journal:  Ann Transl Med       Date:  2020-09

3.  YPC-21661 and YPC-22026, novel small molecules, inhibit ZNF143 activity in vitro and in vivo.

Authors:  Hirotaka Haibara; Ryuta Yamazaki; Yukiko Nishiyama; Masahiro Ono; Tsuneyuki Kobayashi; Atsuko Hokkyo-Itagaki; Fukiko Nishisaka; Hiroyuki Nishiyama; Akinobu Kurita; Takeshi Matsuzaki; Hiroto Izumi; Kimitoshi Kohno
Journal:  Cancer Sci       Date:  2017-04-24       Impact factor: 6.716

4.  Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism.

Authors:  Li Zhou; Feifei Wu; Wangdong Jin; Bo Yan; Xin Chen; Yingfei He; Weiji Yang; Wenlin Du; Qiang Zhang; Yonghua Guo; Qiang Yuan; Xiaoqiao Dong; Wenhua Yu; Jin Zhang; Luwei Xiao; Peijian Tong; Letian Shan; Thomas Efferth
Journal:  Front Pharmacol       Date:  2017-02-27       Impact factor: 5.810

5.  Fangchinoline protects against bone loss in OVX mice via inhibiting osteoclast formation, bone resorption and RANKL-induced signaling.

Authors:  Lin Zhou; Guoju Hong; Shangfu Li; Qian Liu; Fangming Song; Jinmin Zhao; Jinbo Yuan; Jennifer Tickner; Jiake Xu
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

6.  Fangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAK.

Authors:  Jie Shi; Bingyu Guo; Qiang Hui; Peng Chang; Kai Tao
Journal:  Oncol Rep       Date:  2017-05-30       Impact factor: 3.906

Review 7.  Molecular Targets Modulated by Fangchinoline in Tumor Cells and Preclinical Models.

Authors:  Myriam Mérarchi; Gautam Sethi; Lu Fan; Srishti Mishra; Frank Arfuso; Kwang Seok Ahn
Journal:  Molecules       Date:  2018-10-05       Impact factor: 4.411

Review 8.  A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji).

Authors:  Yueping Jiang; Min Liu; Haitao Liu; Shao Liu
Journal:  Phytochem Rev       Date:  2020-04-24       Impact factor: 5.374

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.